To investigate the changes in the levels of homocysteine (Hcy) and C-reactive protein (CRP) in patients with Alzheimer's disease (AD) and analyze their correlation with cognitive and UPDRS functions. The gene discussed is CRP; the disease is early-onset autosomal dominant Alzheimer disease.